MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial
Titel:
MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial
Auteur:
Dreno, Brigitte Thompson, John F Smithers, Bernard Mark Santinami, Mario Jouary, Thomas Gutzmer, Ralf Levchenko, Evgeny Rutkowski, Piotr Grob, Jean-Jacques Korovin, Sergii Drucis, Kamil Grange, Florent Machet, Laurent Hersey, Peter Krajsova, Ivana Testori, Alessandro Conry, Robert Guillot, Bernard Kruit, Wim H J Demidov, Lev Thompson, John A Bondarenko, Igor Jaroszek, Jaroslaw Puig, Susana Cinat, Gabriela Hauschild, Axel Goeman, Jelle J van Houwelingen, Hans C Ulloa-Montoya, Fernando Callegaro, Andrea Dizier, Benjamin Spiessens, Bart Debois, Muriel Brichard, Vincent G Louahed, Jamila Therasse, Patrick Debruyne, Channa Kirkwood, John M